Mylan gains FDA approval for Herceptin biosimilar
Mylan N.V. has received Food and Drug Administration approval for Ogivri (trastuzumab-dkst), a biosimilar oncology drug co-developed with Biocon Ltd.
Pharmacy
CVS survey serves as flu shot reminder
CVS Health has released findings from a poll on flu immunization as it urges families to get their shots during National Influenza Vaccination Week with the approach of peak flu season. A recent CVS survey found that 61% of Americans get a flu vaccine every year or plan to get one this
Lannett to distribute Toprol-XL generic
Lannett Co. has entered into an agreement with Aralez Pharmaceuticals Trading DAC, an Irish designated activity company, to become the exclusive U.S. distributor for metoprolol succinate extended-release tablets, a cardiovascular medication. Financial terms weren’t disclosed.
CVS Health plans real-time benefits visibility
CVS Health has announced that its pharmacy benefits manager (PBM), CVS Caremark, will begin providing real-time visibility to member-specific medication costs and available lower-cost therapeutic alternatives at the point of prescribing and at the pharmacy.
Teva unveils reorganization plan
Just over two months after naming a new chief executive officer, Teva Pharmaceutical Industries Ltd., the world’s largest maker of generic drugs, is reorganizing its business and leadership structure.
Teva offers co-pay program for Gleevec generic
Teva Pharmaceuticals USA has launched a U.S. prescription co-payment assistance program in the U.S. for its imatinib mesylate tablets, a cancer treatment.
PharmaSmart hails updated hypertension guidelines
PharmaSmart International Inc. welcomed new guidelines updating the definition of hypertension and stressing the use of validated devices for measuring blood pressure.
Kaleo to launch Auvi-Q auto-injector for young children
Next year, Kaleo plans to release Auvi-Q 0.1 mg, a version of its epinephrine auto-injector for infants and small children. Kaleo said Monday that the Food and Drug Administration has approved its supplemental New Drug Application (sNDA) for Auvi-Q 0.
Merck gets FDA Approval for GONAL-f prefilled pen
Merck has received approval for a new version of GONAL-f (follitropin alfa injection) prefilled pen from the U.S. Food and Drug Administration (FDA). Known as GONAL-f RFF Redi-ject prefilled pen in the U.S.
AstraZeneca cleared to market Fasenra biologic for asthma
AstraZeneca plans to release Fasenra, its newly approved biologic drug for severe asthma, to U.S. pharmacies in the coming weeks.
Cardinal Health zeroes in on opioid abuse
Building on its efforts to fight the opioid abuse epidemic, Cardinal Health Inc. has launched an initiative targeting one of the nation’s hardest-hit areas.
Diplomat Pharmacy buys LDI for $595 million
Diplomat Pharmacy Inc. plans to acquire St. Louis-based pharmacy benefit manager LDI Integrated Pharmacy Services for in a $595 million cash and stock deal. The move marks the second PBM acquisition this month by Diplomat, the nation’s largest independent specialty pharmacy. On Nov.
PQA appoints new board members
The Pharmacy Quality Alliance (PQA) has named new members to its board of directors and approved its 2018 executive committee. Mary Ann Kliethermes, vice chair of ambulatory care and professor at the Midwestern University Chicago College of Pharmacy, will serve as PQA’s chairman for 2018.
Higi backs redefined levels for high blood pressure
Health screening kiosk maker higi SH LLC welcomed reduced standards for high blood pressure (BP) released this week by the American Heart Association (AHA) and the American College of Cardiology (ACC).
Upsher-Smith parent sells stake in U.S. generics unit
Upsher-Smith Laboratories LLC said its Japan-based parent, Sawai Pharmaceutical Co., has agreed to sell a 20% stake in its Sawai America Inc. subsidiary to Sumitomo Corp. of Americas (SCOA). Under the deal, SCOA — part of global conglomerate Sumitomo Corp.